Charged Alpha Stock Encyclopedia

Rezolute, Inc. (RZLT) Q4 FY2026 — RZLT closed at $3.94 on September 24, down 1.5% for the reporting day. The midday release means this is not an isolated earnings reaction.
Seven of the initial eight upLIFT tumor-study participants met the response threshold, but the trial remains incomplete. The congenital sunRIZE study failed its primary and key secondary endpoints, and FDA review has no stated completion timeline. We examine the clinical evidence, cash runway and dilution behind the price.
THE CALL: SELL (2/5, LOW) — base-case value ~$2.50 vs ~$3.94 today.
KEY METRICS:
- Q4 net loss $20.491M versus $24.390M; FY net loss $77.586M versus $74.412M
- June cash plus marketable securities $107.801M; FY operating cash use $64.635M
- upLIFT: 7 responders among the initial 8 participants; enrollment ongoing
- sunRIZE: primary and key secondary endpoints failed at Week 24; FDA review has no specific timeline
- June common shares plus pre-funded warrants 104.580M; valuation uses 110M model shares
- Conditional base $2.50; $0.25–$7.00 scenarios; weighted value $2.6125
What to watch: Completed tumor data with interpretable safety and durability, a defined and financeable congenital regulatory path, and an updated cash/share count. Topline before end 2026 is a management target; FDA has no specified review deadline.
Full research packet: https://chargedalpha.com/research/rzlt-q4-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Uxin Limited (UXIN) Q2 2026 — UXIN closed September 24 at $1.30, up 19.3% from $1.09, on 16.08 million ADSs traded; the regular-session range was $1.1707 to $1.41.
Uxin nearly doubled retail vehicle volume, but inventory-price pressure drove gross margin to negative 0.7%. The next print must prove that the reset restored vehicle economics while financing and dilution remain central to common-equity value.
THE CALL: HOLD (2/5, LOW) — Probability-weighted value ~$1.12 vs ~$1.30 today.
KEY METRICS:
- Retail volume 19,610, up 88.8% YoY
- Revenue RMB1,151.2M, up 74.9% YoY
- Gross margin −0.7% vs 5.2% YoY
- GAAP operating loss RMB151.9M; net loss RMB178.4M
- Quarterly operating cash flow −RMB63.8M
- Current ratio 0.74×; selected net claims ~$279.9M
- Q3 outlook: retail volume 20,500–21,000 and gross margin above 6%
What to watch: Gross margin above 6%, positive quarterly operating cash flow and full settlement of stated subscription cash with an exact updated ADS count; analyst thresholds, not guidance.
Full research packet: https://chargedalpha.com/research/uxin-q2-2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Costco Wholesale Corporation (COST) Q4 FY2026 — An early after-hours trade was $897.02 at 16:29 ET on September 24, about 0.06% above the $896.48 regular close; this was not a completed post-print session.
Costco delivered 12.4% normalized EPS growth after removing a $0.15 non-recurring tariff-refund benefit. The business remains exceptional, but the early price requires roughly 18.5% annual owner-cash growth for five years in our reverse model, well above the recent 11.7% free-cash-flow CAGR.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$850.00 vs ~$897.02 today.
KEY METRICS:
- Q4 total revenue $95.723B, up 11.1% YoY
- Reported EPS $6.75; normalized EPS $6.60 after removing a $0.15 tariff-refund benefit
- Adjusted comparable sales +6.7%; digitally enabled comps +19.8%
- Paid memberships 84.1M; worldwide renewal 89.8%
- FY2026 free cash flow $9.390B; net cash $15.139B
- Early after-hours reference $897.02 at 16:29 ET September 24
- Base value $850; market-implied five-year cash growth about 18.5%
What to watch: Adjusted comps at least 6%, paid memberships up at least 3.5%, worldwide renewal at least 89.8%, digital growth at least 15% and net cash above $14B; analyst thresholds, not guidance.
Full research packet: https://chargedalpha.com/research/cost-q4-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

TD SYNNEX Corporation (SNX) Q3 FY2026 — A thin pre-market trade was $256.60 at 08:31 ET on September 24, about 10.9% below the $287.89 prior close; the nearby bid/ask spread was wide.
TD SYNNEX reported record operating profit, but quarterly free cash flow was negative $975.6 million. Inventory and receivables are consuming capital, making cash conversion the test of the stronger earnings engine.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$280.00 vs ~$256.60 today.
KEY METRICS:
- Revenue $21,558.4M, up 37.7% YoY
- GAAP operating income $642.9M, up 67.6% YoY
- Non-GAAP diluted EPS $5.68 vs $3.58
- Quarterly OCF −$916.7M; capex $58.9M; FCF −$975.6M
- Inventory $15,291.6M; net debt $4,772.4M, computed
- Q4 adjusted EPS outlook $5.65–$6.15
- Thin pre-market reference $256.60 at 08:31 ET September 24
What to watch: Positive quarterly free cash flow, net debt below $4.5B and adjusted operating margin at least 3.4%; analyst thresholds, not guidance.
Full research packet: https://chargedalpha.com/research/snx-q3-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

General Mills (GIS) Q1 FY2027 — Saved September 23 intraday quote $35.74, +0.82% from prior close; the session was not complete.
Flat organic sales hide a $99M segment-profit decline in Retail and Pet. International and Foodservice offset only $18.3M. Can stabilization become profitable growth?
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$37.00 vs ~$35.74 today.
KEY METRICS:
- Revenue $4,389.5M, down 2.83%; organic sales flat
- Adjusted operating profit $634.0M, down 10.85%
- Adjusted EPS $0.75, down 12.79%
- Retail and Pet segment profit declined $99.0M combined
- International and Foodservice profit improved $18.3M combined
- Pet organic volume −6 pts; margin 16.2% versus 18.5%
- Free cash flow $207.3M; net debt $13,182.5M by primary-line arithmetic
- FY2027 adjusted EPS guidance $3.00–$3.20; HOLD, $37 base value
What to watch: Retail organic sales ≥0%, Pet volume ≥−2 pts and margin ≥17%, with cash conversion progressing toward 95%; reconsider near $29.60 only with the thesis intact.
Full research packet: https://chargedalpha.com/research/gis-q1-fy2027
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Paychex, Inc. (PAYX) Q1 FY2027 — The saved September 23 intraday quote was $105.81, down 7.61% from the prior close; the session had not yet closed.
Paychex paid more in dividends than quarterly free cash flow, even as margins improved. Three cash-flow lines explain most of the decline, and trailing cash still covers the payout. The question is what recovers after integration costs and debt service.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$114.00 vs ~$105.81 at the September 23 intraday snapshot.
KEY METRICS:
- Revenue $1,630.5M, up 5.9% year over year
- GAAP diluted EPS $1.21; adjusted diluted EPS $1.34
- Quarter operating cash $413.5M less $56.1M property/equipment capex = $357.4M FCF
- Cash dividends $424.1M; trailing dividend/FCF payout 80.6%
- Borrowings $4,558.0M; corporate net debt $3,623.8M excluding restricted and client funds
- FY2027 adjusted EPS growth guidance 7%–9%, unchanged
What to watch: Management Solutions growth at least 5%, PEO growth at least 8%, trailing dividend payout below 85% of FCF and corporate net debt declining; reassess at the next quarterly release, expected December 2026.
Full research packet: https://chargedalpha.com/research/payx-q1-fy2027
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Manchester United (MANU) Q4 FY2026 — Reference $20.51 is the September 22 close, before this print; post-print reaction unavailable.
Champions League participation lifts Manchester United’s revenue outlook, but guided EBITDA is roughly flat. Player investment, higher net debt and stadium funding keep the shareholder cash question open.
THE CALL: SELL (3/5, MODERATE) — base-case value ~$13.50 vs ~$20.51 today.
KEY METRICS:
- FY revenue £677.649M, up 1.67%
- FY adjusted EBITDA £216.407M, up 18.37%
- FY net loss £42.954M
- FY27 revenue guide £740–760M; EBITDA £205–225M
- Cash after all investing −£50.859M
- Net debt £621.708M, up £70.839M
- Base $13.50; bear $8; bull $22; weighted $13.55
- Accounts GBP; stock USD; GBPUSD 1.33709 as of Sep 22
What to watch: Positive cash after all investment, net debt below £600M and EBITDA at or above £225M; reconsider near $10.80 only with fundamentals intact.
Full research packet: https://chargedalpha.com/research/manu-q4-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

KB Home (KBH) Q3 FY2026 — Reference price $48.59 from the saved September 22 quote; a post-print reaction is not verified.
Backlog grew, but demand per community weakened. KB Home’s sequential margin recovery meets rising net debt and a book value dominated by inventory.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$50.00 vs ~$48.59 today.
KEY METRICS:
- Revenue $1,297.101M, down 19.96% YoY
- GAAP diluted EPS $1.05 versus $1.61
- Net orders 2,604, down 11.73%
- Monthly orders per community 3.1 versus 3.8
- Backlog 4,398 homes, up 1.50% YoY but down 2.83% sequentially
- Housing gross margin 16.5%; adjusted 16.8%
- Defined net debt $1,950.127M, up $485.764M from fiscal year-end
- Book value $62.56 per share; base fair value $50
What to watch: Orders per community ≥3.5, housing gross margin ≥16.6% without larger charges, leverage stabilizing and verified cash improvement; reconsider near $40 only with fundamentals intact.
Full research packet: https://chargedalpha.com/research/kbh-q3-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

AutoZone, Inc. (AZO) Q4 FY2026 — The reference is the September 21 close of $2,803.25, before this earnings release; no verified post-print move is asserted.
AutoZone’s gross margin rebounded, but tariff refunds and the comparative LIFO benefit explain more than the entire improvement. Commercial growth remains strong while inventory and investment absorb cash.
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$2800.00 vs ~$2803.25 at the September 21 pre-release close.
KEY METRICS:
- Q4 revenue $6,594.879M, up 5.64%
- GAAP diluted EPS $56.05 versus $48.71
- Gross margin +182 bp includes tariff +145 bp and LIFO comparison +105 bp
- FY2026 operating cash $3,302.846M less capex $1,496.255M = FCF $1,806.591M
- Inventory grew 10.1%; domestic same-store sales grew 1.6%
What to watch: Domestic same-store sales above 3%, commercial weekly sales per program above $19K, and inventory growth converging toward sales; review by December 31, 2026.
Full research packet: https://chargedalpha.com/research/azo-q4-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

THOR Industries (THO) Q4 FY2026 — The valuation uses the September 21 pre-print close of $69.94; no post-print reaction is asserted.
THOR promises over $100M of annual earnings improvement once its initiatives are fully implemented. Meanwhile, FY2026 free cash flow fell to $168.8M and dividends plus buybacks ran ahead of it. Can the savings become cash without a retail rebound?
THE CALL: HOLD (3/5, MODERATE) — base-case value ~$70.00 vs ~$69.94 at the September 21 pre-print close.
KEY METRICS:
- Q4 revenue $2,311.628M, down 8.4% YoY
- Q4 gross margin 12.4%, down 230 bps
- Q4 diluted EPS $0.78 vs $2.36
- FY2026 FCF $168.836M = OCF $321.223M less capex $152.387M
- July 31 gross debt less cash $393.780M
- Ultimate $100M+ annual earnings improvement has unquantified timing
What to watch: North American gross margin above 10%, FCF trajectory toward $250M+, and a dated net-savings bridge.
Full research packet: https://chargedalpha.com/research/tho-q4-fy2026
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.